JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1089719, encodeId=ccae1089e1944, content=是否需要在讨论中说明文章局限性？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089720, encodeId=d6021089e2052, content=讨论中局限性怎么撰写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578765, encodeId=2bd85e876547, content=等时间太长了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579895, encodeId=02505e989506, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：投了篇case report ，投的是letter。一审5个月，小修。修完3周返回，3天后接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200728/3621fb8e683a4aa4bb987e43c609b8e2/4602ed3fec154cab8b87d5ff411f0b9b.jpg, createdBy=540e2556613, createdName=syweiang, createdTime=Fri Nov 15 00:00:00 CST 2019, time=2019-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582533, encodeId=3d9c58253365, content=letter算是论著了，你是报道了几个病例？syweiang 2019-11-15 00:00:00 发表: 投了篇case report ，投的是letter。一审5个月，小修。修完3周返回，3天后接收。, beContent=syweiang 2019-11-15 00:00:00 发表: 投了篇case report ，投的是letter。一审5个月，小修。修完3周返回，3天后接收。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59092001947, createdName=澜儿, createdTime=Thu Jan 02 00:00:00 CST 2020, time=2020-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584471, encodeId=177b5844e105, content=1个澜儿 2020-01-02 00:00:00 发表: letter算是论著了，你是报道了几个病例？, beContent=澜儿 2020-01-02 00:00:00 发表: letter算是论著了，你是报道了几个病例？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200728/3621fb8e683a4aa4bb987e43c609b8e2/4602ed3fec154cab8b87d5ff411f0b9b.jpg, createdBy=540e2556613, createdName=syweiang, createdTime=Sun Feb 09 00:00:00 CST 2020, time=2020-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908360, encodeId=00fb908360f0, content=审稿费多少呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3a55434745, createdName=ms3000000661874644, createdTime=Tue Dec 15 22:55:34 CST 2020, time=2020-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067834, encodeId=df29106e834d6, content=要是有作者不填确认邮箱会不会影响审稿呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32c32236172, createdName=12133f96m16(暂无昵称), createdTime=Sun Nov 07 17:38:18 CST 2021, time=2021-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553955, encodeId=11f255395527, content=返修意见嫌只用了一个细胞株，用了三个月时间，按要求加了两个细胞株的实验，又审稿两个月，拒了。理由是，只有25%的收稿率。一审你给我拒了啊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=268, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=383a2302324, createdName=1220c4c1m20(暂无昵称), createdTime=Wed Mar 21 10:50:00 CST 2018, time=2018-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=541352, encodeId=a4f254135228, content=马马虎虎，能毕业就行，我师兄去年发表了一篇，也算成功毕业，就万事大吉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=333, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=huabing, createdTime=Fri Jul 14 18:46:00 CST 2017, time=2017-07-14, status=1, ipAttribution=)]

2021-12-28 msSSSSSD

是否需要在讨论中说明文章局限性？

44 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1089719, encodeId=ccae1089e1944, content=是否需要在讨论中说明文章局限性？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089720, encodeId=d6021089e2052, content=讨论中局限性怎么撰写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578765, encodeId=2bd85e876547, content=等时间太长了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579895, encodeId=02505e989506, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：投了篇case report ，投的是letter。一审5个月，小修。修完3周返回，3天后接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200728/3621fb8e683a4aa4bb987e43c609b8e2/4602ed3fec154cab8b87d5ff411f0b9b.jpg, createdBy=540e2556613, createdName=syweiang, createdTime=Fri Nov 15 00:00:00 CST 2019, time=2019-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582533, encodeId=3d9c58253365, content=letter算是论著了，你是报道了几个病例？syweiang 2019-11-15 00:00:00 发表: 投了篇case report ，投的是letter。一审5个月，小修。修完3周返回，3天后接收。, beContent=syweiang 2019-11-15 00:00:00 发表: 投了篇case report ，投的是letter。一审5个月，小修。修完3周返回，3天后接收。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59092001947, createdName=澜儿, createdTime=Thu Jan 02 00:00:00 CST 2020, time=2020-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584471, encodeId=177b5844e105, content=1个澜儿 2020-01-02 00:00:00 发表: letter算是论著了，你是报道了几个病例？, beContent=澜儿 2020-01-02 00:00:00 发表: letter算是论著了，你是报道了几个病例？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200728/3621fb8e683a4aa4bb987e43c609b8e2/4602ed3fec154cab8b87d5ff411f0b9b.jpg, createdBy=540e2556613, createdName=syweiang, createdTime=Sun Feb 09 00:00:00 CST 2020, time=2020-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908360, encodeId=00fb908360f0, content=审稿费多少呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3a55434745, createdName=ms3000000661874644, createdTime=Tue Dec 15 22:55:34 CST 2020, time=2020-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067834, encodeId=df29106e834d6, content=要是有作者不填确认邮箱会不会影响审稿呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32c32236172, createdName=12133f96m16(暂无昵称), createdTime=Sun Nov 07 17:38:18 CST 2021, time=2021-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553955, encodeId=11f255395527, content=返修意见嫌只用了一个细胞株，用了三个月时间，按要求加了两个细胞株的实验，又审稿两个月，拒了。理由是，只有25%的收稿率。一审你给我拒了啊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=268, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=383a2302324, createdName=1220c4c1m20(暂无昵称), createdTime=Wed Mar 21 10:50:00 CST 2018, time=2018-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=541352, encodeId=a4f254135228, content=马马虎虎，能毕业就行，我师兄去年发表了一篇，也算成功毕业，就万事大吉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=333, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=huabing, createdTime=Fri Jul 14 18:46:00 CST 2017, time=2017-07-14, status=1, ipAttribution=)]

2021-12-28 学医的彭于晏

讨论中局限性怎么撰写？

40 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1089719, encodeId=ccae1089e1944, content=是否需要在讨论中说明文章局限性？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089720, encodeId=d6021089e2052, content=讨论中局限性怎么撰写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578765, encodeId=2bd85e876547, content=等时间太长了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579895, encodeId=02505e989506, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：投了篇case report ，投的是letter。一审5个月，小修。修完3周返回，3天后接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200728/3621fb8e683a4aa4bb987e43c609b8e2/4602ed3fec154cab8b87d5ff411f0b9b.jpg, createdBy=540e2556613, createdName=syweiang, createdTime=Fri Nov 15 00:00:00 CST 2019, time=2019-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582533, encodeId=3d9c58253365, content=letter算是论著了，你是报道了几个病例？syweiang 2019-11-15 00:00:00 发表: 投了篇case report ，投的是letter。一审5个月，小修。修完3周返回，3天后接收。, beContent=syweiang 2019-11-15 00:00:00 发表: 投了篇case report ，投的是letter。一审5个月，小修。修完3周返回，3天后接收。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59092001947, createdName=澜儿, createdTime=Thu Jan 02 00:00:00 CST 2020, time=2020-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584471, encodeId=177b5844e105, content=1个澜儿 2020-01-02 00:00:00 发表: letter算是论著了，你是报道了几个病例？, beContent=澜儿 2020-01-02 00:00:00 发表: letter算是论著了，你是报道了几个病例？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200728/3621fb8e683a4aa4bb987e43c609b8e2/4602ed3fec154cab8b87d5ff411f0b9b.jpg, createdBy=540e2556613, createdName=syweiang, createdTime=Sun Feb 09 00:00:00 CST 2020, time=2020-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908360, encodeId=00fb908360f0, content=审稿费多少呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3a55434745, createdName=ms3000000661874644, createdTime=Tue Dec 15 22:55:34 CST 2020, time=2020-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067834, encodeId=df29106e834d6, content=要是有作者不填确认邮箱会不会影响审稿呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32c32236172, createdName=12133f96m16(暂无昵称), createdTime=Sun Nov 07 17:38:18 CST 2021, time=2021-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553955, encodeId=11f255395527, content=返修意见嫌只用了一个细胞株，用了三个月时间，按要求加了两个细胞株的实验，又审稿两个月，拒了。理由是，只有25%的收稿率。一审你给我拒了啊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=268, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=383a2302324, createdName=1220c4c1m20(暂无昵称), createdTime=Wed Mar 21 10:50:00 CST 2018, time=2018-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=541352, encodeId=a4f254135228, content=马马虎虎，能毕业就行，我师兄去年发表了一篇，也算成功毕业，就万事大吉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=333, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=huabing, createdTime=Fri Jul 14 18:46:00 CST 2017, time=2017-07-14, status=1, ipAttribution=)]

2019-10-25 147612bem32暂无昵称

等时间太长了

119 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1089719, encodeId=ccae1089e1944, content=是否需要在讨论中说明文章局限性？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089720, encodeId=d6021089e2052, content=讨论中局限性怎么撰写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578765, encodeId=2bd85e876547, content=等时间太长了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579895, encodeId=02505e989506, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：投了篇case report ，投的是letter。一审5个月，小修。修完3周返回，3天后接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200728/3621fb8e683a4aa4bb987e43c609b8e2/4602ed3fec154cab8b87d5ff411f0b9b.jpg, createdBy=540e2556613, createdName=syweiang, createdTime=Fri Nov 15 00:00:00 CST 2019, time=2019-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582533, encodeId=3d9c58253365, content=letter算是论著了，你是报道了几个病例？syweiang 2019-11-15 00:00:00 发表: 投了篇case report ，投的是letter。一审5个月，小修。修完3周返回，3天后接收。, beContent=syweiang 2019-11-15 00:00:00 发表: 投了篇case report ，投的是letter。一审5个月，小修。修完3周返回，3天后接收。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59092001947, createdName=澜儿, createdTime=Thu Jan 02 00:00:00 CST 2020, time=2020-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584471, encodeId=177b5844e105, content=1个澜儿 2020-01-02 00:00:00 发表: letter算是论著了，你是报道了几个病例？, beContent=澜儿 2020-01-02 00:00:00 发表: letter算是论著了，你是报道了几个病例？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200728/3621fb8e683a4aa4bb987e43c609b8e2/4602ed3fec154cab8b87d5ff411f0b9b.jpg, createdBy=540e2556613, createdName=syweiang, createdTime=Sun Feb 09 00:00:00 CST 2020, time=2020-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908360, encodeId=00fb908360f0, content=审稿费多少呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3a55434745, createdName=ms3000000661874644, createdTime=Tue Dec 15 22:55:34 CST 2020, time=2020-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067834, encodeId=df29106e834d6, content=要是有作者不填确认邮箱会不会影响审稿呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32c32236172, createdName=12133f96m16(暂无昵称), createdTime=Sun Nov 07 17:38:18 CST 2021, time=2021-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553955, encodeId=11f255395527, content=返修意见嫌只用了一个细胞株，用了三个月时间，按要求加了两个细胞株的实验，又审稿两个月，拒了。理由是，只有25%的收稿率。一审你给我拒了啊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=268, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=383a2302324, createdName=1220c4c1m20(暂无昵称), createdTime=Wed Mar 21 10:50:00 CST 2018, time=2018-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=541352, encodeId=a4f254135228, content=马马虎虎，能毕业就行，我师兄去年发表了一篇，也算成功毕业，就万事大吉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=333, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=huabing, createdTime=Fri Jul 14 18:46:00 CST 2017, time=2017-07-14, status=1, ipAttribution=)]

2019-11-15 syweiang

审稿速度:6.0 | 投稿命中率:75.0
经验分享：投了篇case report ，投的是letter。一审5个月，小修。修完3周返回，3天后接收。

149 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1089719, encodeId=ccae1089e1944, content=是否需要在讨论中说明文章局限性？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089720, encodeId=d6021089e2052, content=讨论中局限性怎么撰写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578765, encodeId=2bd85e876547, content=等时间太长了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579895, encodeId=02505e989506, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：投了篇case report ，投的是letter。一审5个月，小修。修完3周返回，3天后接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200728/3621fb8e683a4aa4bb987e43c609b8e2/4602ed3fec154cab8b87d5ff411f0b9b.jpg, createdBy=540e2556613, createdName=syweiang, createdTime=Fri Nov 15 00:00:00 CST 2019, time=2019-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582533, encodeId=3d9c58253365, content=letter算是论著了，你是报道了几个病例？syweiang 2019-11-15 00:00:00 发表: 投了篇case report ，投的是letter。一审5个月，小修。修完3周返回，3天后接收。, beContent=syweiang 2019-11-15 00:00:00 发表: 投了篇case report ，投的是letter。一审5个月，小修。修完3周返回，3天后接收。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59092001947, createdName=澜儿, createdTime=Thu Jan 02 00:00:00 CST 2020, time=2020-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584471, encodeId=177b5844e105, content=1个澜儿 2020-01-02 00:00:00 发表: letter算是论著了，你是报道了几个病例？, beContent=澜儿 2020-01-02 00:00:00 发表: letter算是论著了，你是报道了几个病例？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200728/3621fb8e683a4aa4bb987e43c609b8e2/4602ed3fec154cab8b87d5ff411f0b9b.jpg, createdBy=540e2556613, createdName=syweiang, createdTime=Sun Feb 09 00:00:00 CST 2020, time=2020-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908360, encodeId=00fb908360f0, content=审稿费多少呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3a55434745, createdName=ms3000000661874644, createdTime=Tue Dec 15 22:55:34 CST 2020, time=2020-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067834, encodeId=df29106e834d6, content=要是有作者不填确认邮箱会不会影响审稿呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32c32236172, createdName=12133f96m16(暂无昵称), createdTime=Sun Nov 07 17:38:18 CST 2021, time=2021-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553955, encodeId=11f255395527, content=返修意见嫌只用了一个细胞株，用了三个月时间，按要求加了两个细胞株的实验，又审稿两个月，拒了。理由是，只有25%的收稿率。一审你给我拒了啊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=268, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=383a2302324, createdName=1220c4c1m20(暂无昵称), createdTime=Wed Mar 21 10:50:00 CST 2018, time=2018-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=541352, encodeId=a4f254135228, content=马马虎虎，能毕业就行，我师兄去年发表了一篇，也算成功毕业，就万事大吉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=333, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=huabing, createdTime=Fri Jul 14 18:46:00 CST 2017, time=2017-07-14, status=1, ipAttribution=)]

2020-01-02 澜儿

letter算是论著了，你是报道了几个病例？syweiang 2019-11-15 00:00:00 发表:
投了篇case report ，投的是letter。一审5个月，小修。修完3周返回，3天后接收。

syweiang 2019-11-15 00:00:00 发表: 投了篇case report ，投的是letter。一审5个月，小修。修完3周返回，3天后接收。

152 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1089719, encodeId=ccae1089e1944, content=是否需要在讨论中说明文章局限性？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089720, encodeId=d6021089e2052, content=讨论中局限性怎么撰写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578765, encodeId=2bd85e876547, content=等时间太长了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579895, encodeId=02505e989506, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：投了篇case report ，投的是letter。一审5个月，小修。修完3周返回，3天后接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200728/3621fb8e683a4aa4bb987e43c609b8e2/4602ed3fec154cab8b87d5ff411f0b9b.jpg, createdBy=540e2556613, createdName=syweiang, createdTime=Fri Nov 15 00:00:00 CST 2019, time=2019-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582533, encodeId=3d9c58253365, content=letter算是论著了，你是报道了几个病例？syweiang 2019-11-15 00:00:00 发表: 投了篇case report ，投的是letter。一审5个月，小修。修完3周返回，3天后接收。, beContent=syweiang 2019-11-15 00:00:00 发表: 投了篇case report ，投的是letter。一审5个月，小修。修完3周返回，3天后接收。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59092001947, createdName=澜儿, createdTime=Thu Jan 02 00:00:00 CST 2020, time=2020-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584471, encodeId=177b5844e105, content=1个澜儿 2020-01-02 00:00:00 发表: letter算是论著了，你是报道了几个病例？, beContent=澜儿 2020-01-02 00:00:00 发表: letter算是论著了，你是报道了几个病例？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200728/3621fb8e683a4aa4bb987e43c609b8e2/4602ed3fec154cab8b87d5ff411f0b9b.jpg, createdBy=540e2556613, createdName=syweiang, createdTime=Sun Feb 09 00:00:00 CST 2020, time=2020-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908360, encodeId=00fb908360f0, content=审稿费多少呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3a55434745, createdName=ms3000000661874644, createdTime=Tue Dec 15 22:55:34 CST 2020, time=2020-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067834, encodeId=df29106e834d6, content=要是有作者不填确认邮箱会不会影响审稿呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32c32236172, createdName=12133f96m16(暂无昵称), createdTime=Sun Nov 07 17:38:18 CST 2021, time=2021-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553955, encodeId=11f255395527, content=返修意见嫌只用了一个细胞株，用了三个月时间，按要求加了两个细胞株的实验，又审稿两个月，拒了。理由是，只有25%的收稿率。一审你给我拒了啊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=268, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=383a2302324, createdName=1220c4c1m20(暂无昵称), createdTime=Wed Mar 21 10:50:00 CST 2018, time=2018-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=541352, encodeId=a4f254135228, content=马马虎虎，能毕业就行，我师兄去年发表了一篇，也算成功毕业，就万事大吉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=333, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=huabing, createdTime=Fri Jul 14 18:46:00 CST 2017, time=2017-07-14, status=1, ipAttribution=)]

2020-02-09 syweiang

1个澜儿 2020-01-02 00:00:00 发表:
letter算是论著了，你是报道了几个病例？

澜儿 2020-01-02 00:00:00 发表: letter算是论著了，你是报道了几个病例？

126 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1089719, encodeId=ccae1089e1944, content=是否需要在讨论中说明文章局限性？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089720, encodeId=d6021089e2052, content=讨论中局限性怎么撰写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578765, encodeId=2bd85e876547, content=等时间太长了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579895, encodeId=02505e989506, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：投了篇case report ，投的是letter。一审5个月，小修。修完3周返回，3天后接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200728/3621fb8e683a4aa4bb987e43c609b8e2/4602ed3fec154cab8b87d5ff411f0b9b.jpg, createdBy=540e2556613, createdName=syweiang, createdTime=Fri Nov 15 00:00:00 CST 2019, time=2019-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582533, encodeId=3d9c58253365, content=letter算是论著了，你是报道了几个病例？syweiang 2019-11-15 00:00:00 发表: 投了篇case report ，投的是letter。一审5个月，小修。修完3周返回，3天后接收。, beContent=syweiang 2019-11-15 00:00:00 发表: 投了篇case report ，投的是letter。一审5个月，小修。修完3周返回，3天后接收。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59092001947, createdName=澜儿, createdTime=Thu Jan 02 00:00:00 CST 2020, time=2020-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584471, encodeId=177b5844e105, content=1个澜儿 2020-01-02 00:00:00 发表: letter算是论著了，你是报道了几个病例？, beContent=澜儿 2020-01-02 00:00:00 发表: letter算是论著了，你是报道了几个病例？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200728/3621fb8e683a4aa4bb987e43c609b8e2/4602ed3fec154cab8b87d5ff411f0b9b.jpg, createdBy=540e2556613, createdName=syweiang, createdTime=Sun Feb 09 00:00:00 CST 2020, time=2020-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908360, encodeId=00fb908360f0, content=审稿费多少呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3a55434745, createdName=ms3000000661874644, createdTime=Tue Dec 15 22:55:34 CST 2020, time=2020-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067834, encodeId=df29106e834d6, content=要是有作者不填确认邮箱会不会影响审稿呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32c32236172, createdName=12133f96m16(暂无昵称), createdTime=Sun Nov 07 17:38:18 CST 2021, time=2021-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553955, encodeId=11f255395527, content=返修意见嫌只用了一个细胞株，用了三个月时间，按要求加了两个细胞株的实验，又审稿两个月，拒了。理由是，只有25%的收稿率。一审你给我拒了啊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=268, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=383a2302324, createdName=1220c4c1m20(暂无昵称), createdTime=Wed Mar 21 10:50:00 CST 2018, time=2018-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=541352, encodeId=a4f254135228, content=马马虎虎，能毕业就行，我师兄去年发表了一篇，也算成功毕业，就万事大吉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=333, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=huabing, createdTime=Fri Jul 14 18:46:00 CST 2017, time=2017-07-14, status=1, ipAttribution=)]

2020-12-15 ms3000000661874644

审稿费多少呢？

114 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=1089719, encodeId=ccae1089e1944, content=是否需要在讨论中说明文章局限性？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089720, encodeId=d6021089e2052, content=讨论中局限性怎么撰写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578765, encodeId=2bd85e876547, content=等时间太长了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579895, encodeId=02505e989506, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：投了篇case report ，投的是letter。一审5个月，小修。修完3周返回，3天后接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200728/3621fb8e683a4aa4bb987e43c609b8e2/4602ed3fec154cab8b87d5ff411f0b9b.jpg, createdBy=540e2556613, createdName=syweiang, createdTime=Fri Nov 15 00:00:00 CST 2019, time=2019-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582533, encodeId=3d9c58253365, content=letter算是论著了，你是报道了几个病例？syweiang 2019-11-15 00:00:00 发表: 投了篇case report ，投的是letter。一审5个月，小修。修完3周返回，3天后接收。, beContent=syweiang 2019-11-15 00:00:00 发表: 投了篇case report ，投的是letter。一审5个月，小修。修完3周返回，3天后接收。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59092001947, createdName=澜儿, createdTime=Thu Jan 02 00:00:00 CST 2020, time=2020-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584471, encodeId=177b5844e105, content=1个澜儿 2020-01-02 00:00:00 发表: letter算是论著了，你是报道了几个病例？, beContent=澜儿 2020-01-02 00:00:00 发表: letter算是论著了，你是报道了几个病例？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200728/3621fb8e683a4aa4bb987e43c609b8e2/4602ed3fec154cab8b87d5ff411f0b9b.jpg, createdBy=540e2556613, createdName=syweiang, createdTime=Sun Feb 09 00:00:00 CST 2020, time=2020-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908360, encodeId=00fb908360f0, content=审稿费多少呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3a55434745, createdName=ms3000000661874644, createdTime=Tue Dec 15 22:55:34 CST 2020, time=2020-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067834, encodeId=df29106e834d6, content=要是有作者不填确认邮箱会不会影响审稿呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32c32236172, createdName=12133f96m16(暂无昵称), createdTime=Sun Nov 07 17:38:18 CST 2021, time=2021-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553955, encodeId=11f255395527, content=返修意见嫌只用了一个细胞株，用了三个月时间，按要求加了两个细胞株的实验，又审稿两个月，拒了。理由是，只有25%的收稿率。一审你给我拒了啊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=268, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=383a2302324, createdName=1220c4c1m20(暂无昵称), createdTime=Wed Mar 21 10:50:00 CST 2018, time=2018-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=541352, encodeId=a4f254135228, content=马马虎虎，能毕业就行，我师兄去年发表了一篇，也算成功毕业，就万事大吉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=333, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=huabing, createdTime=Fri Jul 14 18:46:00 CST 2017, time=2017-07-14, status=1, ipAttribution=)]

2021-11-07 12133f96m16(暂无昵称)

要是有作者不填确认邮箱会不会影响审稿呢

62 0

[GetPortalCommentsPageByObjectIdResponse(id=1089719, encodeId=ccae1089e1944, content=是否需要在讨论中说明文章局限性？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089720, encodeId=d6021089e2052, content=讨论中局限性怎么撰写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578765, encodeId=2bd85e876547, content=等时间太长了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579895, encodeId=02505e989506, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：投了篇case report ，投的是letter。一审5个月，小修。修完3周返回，3天后接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200728/3621fb8e683a4aa4bb987e43c609b8e2/4602ed3fec154cab8b87d5ff411f0b9b.jpg, createdBy=540e2556613, createdName=syweiang, createdTime=Fri Nov 15 00:00:00 CST 2019, time=2019-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582533, encodeId=3d9c58253365, content=letter算是论著了，你是报道了几个病例？syweiang 2019-11-15 00:00:00 发表: 投了篇case report ，投的是letter。一审5个月，小修。修完3周返回，3天后接收。, beContent=syweiang 2019-11-15 00:00:00 发表: 投了篇case report ，投的是letter。一审5个月，小修。修完3周返回，3天后接收。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59092001947, createdName=澜儿, createdTime=Thu Jan 02 00:00:00 CST 2020, time=2020-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584471, encodeId=177b5844e105, content=1个澜儿 2020-01-02 00:00:00 发表: letter算是论著了，你是报道了几个病例？, beContent=澜儿 2020-01-02 00:00:00 发表: letter算是论著了，你是报道了几个病例？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200728/3621fb8e683a4aa4bb987e43c609b8e2/4602ed3fec154cab8b87d5ff411f0b9b.jpg, createdBy=540e2556613, createdName=syweiang, createdTime=Sun Feb 09 00:00:00 CST 2020, time=2020-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908360, encodeId=00fb908360f0, content=审稿费多少呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3a55434745, createdName=ms3000000661874644, createdTime=Tue Dec 15 22:55:34 CST 2020, time=2020-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067834, encodeId=df29106e834d6, content=要是有作者不填确认邮箱会不会影响审稿呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32c32236172, createdName=12133f96m16(暂无昵称), createdTime=Sun Nov 07 17:38:18 CST 2021, time=2021-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553955, encodeId=11f255395527, content=返修意见嫌只用了一个细胞株，用了三个月时间，按要求加了两个细胞株的实验，又审稿两个月，拒了。理由是，只有25%的收稿率。一审你给我拒了啊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=268, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=383a2302324, createdName=1220c4c1m20(暂无昵称), createdTime=Wed Mar 21 10:50:00 CST 2018, time=2018-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=541352, encodeId=a4f254135228, content=马马虎虎，能毕业就行，我师兄去年发表了一篇，也算成功毕业，就万事大吉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=333, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=huabing, createdTime=Fri Jul 14 18:46:00 CST 2017, time=2017-07-14, status=1, ipAttribution=)]

2018-03-21 1220c4c1m20(暂无昵称)

返修意见嫌只用了一个细胞株，用了三个月时间，按要求加了两个细胞株的实验，又审稿两个月，拒了。理由是，只有25%的收稿率。一审你给我拒了啊！

268 0

[GetPortalCommentsPageByObjectIdResponse(id=1089719, encodeId=ccae1089e1944, content=是否需要在讨论中说明文章局限性？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089720, encodeId=d6021089e2052, content=讨论中局限性怎么撰写？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578765, encodeId=2bd85e876547, content=等时间太长了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=119, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=579895, encodeId=02505e989506, content=审稿速度:6.0 | 投稿命中率:75.0 经验分享：投了篇case report ，投的是letter。一审5个月，小修。修完3周返回，3天后接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=149, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200728/3621fb8e683a4aa4bb987e43c609b8e2/4602ed3fec154cab8b87d5ff411f0b9b.jpg, createdBy=540e2556613, createdName=syweiang, createdTime=Fri Nov 15 00:00:00 CST 2019, time=2019-11-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=582533, encodeId=3d9c58253365, content=letter算是论著了，你是报道了几个病例？syweiang 2019-11-15 00:00:00 发表: 投了篇case report ，投的是letter。一审5个月，小修。修完3周返回，3天后接收。, beContent=syweiang 2019-11-15 00:00:00 发表: 投了篇case report ，投的是letter。一审5个月，小修。修完3周返回，3天后接收。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=152, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=59092001947, createdName=澜儿, createdTime=Thu Jan 02 00:00:00 CST 2020, time=2020-01-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584471, encodeId=177b5844e105, content=1个澜儿 2020-01-02 00:00:00 发表: letter算是论著了，你是报道了几个病例？, beContent=澜儿 2020-01-02 00:00:00 发表: letter算是论著了，你是报道了几个病例？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200728/3621fb8e683a4aa4bb987e43c609b8e2/4602ed3fec154cab8b87d5ff411f0b9b.jpg, createdBy=540e2556613, createdName=syweiang, createdTime=Sun Feb 09 00:00:00 CST 2020, time=2020-02-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908360, encodeId=00fb908360f0, content=审稿费多少呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=114, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3a55434745, createdName=ms3000000661874644, createdTime=Tue Dec 15 22:55:34 CST 2020, time=2020-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067834, encodeId=df29106e834d6, content=要是有作者不填确认邮箱会不会影响审稿呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=32c32236172, createdName=12133f96m16(暂无昵称), createdTime=Sun Nov 07 17:38:18 CST 2021, time=2021-11-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553955, encodeId=11f255395527, content=返修意见嫌只用了一个细胞株，用了三个月时间，按要求加了两个细胞株的实验，又审稿两个月，拒了。理由是，只有25%的收稿率。一审你给我拒了啊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=268, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=383a2302324, createdName=1220c4c1m20(暂无昵称), createdTime=Wed Mar 21 10:50:00 CST 2018, time=2018-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=541352, encodeId=a4f254135228, content=马马虎虎，能毕业就行，我师兄去年发表了一篇，也算成功毕业，就万事大吉了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=333, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=huabing, createdTime=Fri Jul 14 18:46:00 CST 2017, time=2017-07-14, status=1, ipAttribution=)]

2017-07-14 huabing

马马虎虎，能毕业就行，我师兄去年发表了一篇，也算成功毕业，就万事大吉了

333 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务